FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental ANDA for Apotex Corp. to market GLIPIZIDE as a generic tablet for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)